Tritium labelling of two potent dopamine D receptor agonists at high specific activity.

An efficient method is described to radiolabel several dopamine D receptor agonists with tritium at high specific activity.

High specific activity tritiation of the pyridazin-3-one histamine H3 receptor inverse agonist CEP-27088.

Methods are presented to tritiate and characterize radioligand (3).

Tritiation of several antihypertensive agents at high specific activity.

Methods are described to synthesize and characterize tritium labeled analogues of telmisartan and lacidipine.